[Male fertility in Hodgkin's disease before and after chemotherapy (author's transl)].
Sperm examinations and/or measurements of plasma FSH, LH and testosterone were performed on 54 patients with Hodgkin's disease before and/or after 3 or 6 courses of multiagent chemotherapy (MOPP). In 24 patients without constitutional symptoms the results of fresh and frozen sperm examination were similar to those of a fertile control population. In 23 patients, pretreatment hormone levels were identical with those of controls. During the first year following completion of chemotherapy all patients had azoospermia and high FSH levels. From the second year onwards, 2 out of 16 patients had normal spermatogenesis (the wife of one of these gave birth to a healthy child), while 4 had grossly deficient spermatogenesis and 10 azoospermia. All male patients suffering from Hodgkin's disease should be asked to give sperm for freezing before chemotherapy and should be informed that spermatogenesis may be resumed from the second posttreatment year.
D000328:Adult; D004359:Drug Therapy, Combination; D005298:Fertility; D006689:Hodgkin Disease / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D006728:Hormones / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D013091:Spermatogenesis; D013997:Time Factors
D006728:Hormones
La fertilité des jeunes hommes ateints de la maladie de Hodgkin avant et après chimiothérapie.